Eisai
4523.T
#2229
Rank
NZ$15.45 B
Marketcap
NZ$54.74
Share price
-0.46%
Change (1 day)
-8.66%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.51. In 2026 the company made an earnings per share (EPS) of NZ$1.51 a decrease over its 2025 EPS that were of NZ$1.91.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026NZ$1.51-21.04%
2025NZ$1.9111.85%
2024NZ$1.71-32.63%
2023NZ$2.535.52%
2022NZ$2.40-74.01%
2021NZ$9.24-66.58%
2020NZ$27.6598.24%
2019NZ$13.9517.01%
2018NZ$11.9237.78%
2017NZ$8.65-27.62%
2016NZ$11.9535.33%
2015NZ$8.83-2.82%
2014NZ$9.09-27.66%
2013NZ$12.56-27.49%
2012NZ$17.33-12.67%
2011NZ$19.8488.08%
2010NZ$10.55-11.06%
2009NZ$11.86-390.15%
2008NZ-$4.09-127.78%
2007NZ$14.72347.11%
2006NZ$3.294.38%
2005NZ$3.157.4%
2004NZ$2.9443.03%
2003NZ$2.0525.09%
2002NZ$1.6452.67%
2001NZ$1.0869.76%
2000NZ$0.63